Updated:
Lumanity
Lumanity is a other based in Morristown; the Altss profile covers its classification, headquarters, registration, AUM band, and key contacts for...
Lumanity
Lumanity provides end-to-end commercialization support, addressing market complexities from initial strategy to market execution.
General information
Firm type
other
Location
Region
North America
Country
United States
City
Morristown
Corporate office
Morristown, NJ, United States
Additional offices
London, United Kingdom · Sheffield, United Kingdom · Farnham, United Kingdom · Grünwald, Germany · Nuremberg, Germany · Rotkreuz, Switzerland · Edinburgh, United Kingdom · Utrecht, Netherlands · Gurugram, India · Boston, MA, United States · New York, NY, United States
Sector focus
Frequently asked questions
Who runs investment decisions at Lumanity?
Lumanity does not operate as an investment firm; it is a strategic services partnership providing commercialization support to life-sciences companies. The firm's leadership, including specific named principals, is not publicly disclosed.
How does Lumanity source proprietary deal flow?
Lumanity does not describe a deal-flow sourcing model because it does not manage investments. Instead, it sources client engagements through its reputation with top biopharma companies and biotech firms, leveraging its multidisciplinary capabilities (strategy, evidence, engagement, technology, and AI) as described on its website.
Is Lumanity structured as a single family office or does it operate more like a venture firm?
Lumanity is neither a family office nor a venture firm. It is a strategic services provider that delivers commercialization support to the life-sciences industry, employing 1,200 experts globally (per the firm).
Does Lumanity participate in fund commitments or only direct deals?
Lumanity does not participate in fund commitments or direct deals. Its business model centers on fee-for-service engagements with pharmaceutical and biotech clients, as evidenced by its published case studies.
What investment stages does Lumanity typically target?
Lumanity does not target investment stages. Its work spans the full commercialization lifecycle of medicines, from early strategy and evidence generation through market access and engagement — as illustrated in its case studies on inflation reduction act negotiations and cell-and-gene therapy business creation.
How is Lumanity related to its affiliated brands (Leith, Stripe Communications, PHARMO)?
Lumanity's contact page lists Leith, Stripe Communications, and PHARMO as associated businesses. Leith and Stripe Communications share an office in Edinburgh, and PHARMO is based in Utrecht. The exact corporate relationship, such as ownership or partnership, is not publicly specified.
Where does the underlying wealth come from?
Lumanity is not a wealth-management entity. Its origins and capital sources are not publicly disclosed, and the firm does not present itself as managing any family or institutional wealth.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: